Multibagger pharma stock under Rs 70 to keep under the radar as company announces positive quarterly results (Q1FY25)
From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years.
Today, shares of Sigachi Industries gained 2.50 per cent to an intraday high of Rs 63.79 per share from its previous closing of Rs 62.24. The company has a market cap of over Rs 2,000 crore and has delivered good profit growth of 25 per cent CAGR over the last 5 years.
The company announced positive Quarterly Results (Q1FY25) and annual results (FY24) for the financial year 2024. According to quarterly results, revenue increased by 13 per cent to Rs 95.71 crore, PBT increased by 11.5 per cent to Rs 16.39 crore and PAT increased by 17.3 per cent to Rs 12.76 crore in Q1FY25 compared to Q1FY24. In its annual results, revenue increased by 32.1 per cent to Rs 398.96 crore PBT increased by 28.1 per cent to Rs 69.77 crore and PAT increased by 31.5 per cent to Rs 57.27 crore in FY24 compared to FY23.
DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.
Sigachi Industries Limited, publicly listed in NSE and BSE, is a globally recognized pharmaceutical company known for its unwavering commitment to delivering high-quality excipients, vitamin mineral nutrient blends, APIs, and O&M services. With over 33 years of industry experience, Sigachi has emerged as a trusted partner for pharmaceutical and nutraceutical companies spread across 62 countries. The company's diverse product portfolio is manufactured in 5 multilocational facilities present in Telangana, Gujarat and Karnataka which hold global standard certifications. Being headquartered in Hyderabad, Sigachi Industries Limited has subsidiaries in the US and UAE.
The company ex-traded the stock split of equity shares from Rs 10 to Rs 1 on October 09, 2023. From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years. Investors should keep an eye on this small-cap pharma stock.
Disclaimer: The article is for informational purposes only and not investment advice.
Also Read: Rs 13,018 crore order book: TATA Group-multibagger solar microgrid power company announces Q1FY25 results & acquire 40 per cent stake in Khorlochhu Hydro Power Ltd